Mounjaro (tirzepatide) and Trulicity (dulaglutide) are both FDA-approved GLP-1 receptor agonists made by Eli Lilly and are used to treat type 2 diabetes
J., Bharatha, A., Montanera, W
This is especially true for compounds like GLP-1 and GIP that can greatly impact metabolic health
Our experienced staff will discuss your weight loss goals through detailed consultations and devise a plan that aligns with your desired weight loss goals
Although these agents produce substantial and sustained weight reduction, emerging clinical observations suggest that chronic therapy may be accompanied by changes in lean mass trajectory, reduced protein intake, and micronutrient insufficiency
O/ura Labs supplies high-purity GHK-Cu peptide selected for formulation integrity, stability, and consistency